Pharmaceutical Industry Review, December No 4 (103) 2024 Key Sections and Articles #4 (103) 2024


EDITORIAL 6 Another year of challenges and hopes for Ukraine's


pharmaceutical industry. Svitlana Havrylenko 30


COVER STORY: Solid Dosage Forms


30 33


PHARMA 4.0, SERIALIZATION, AGGREGATION, TRACK & TRACE


8


Top priorities for 2025 for every pharma professional. Transform your pharmaceutical operations with SATT PLATFORM®


10 Application of blockchain technology in the pharmaceutical industry 36 . SoftGroup 36


Coating tablets — getting the best results from the start. New lab coater offers greater flexibility. L.B. Bohle


Comparing approaches to manufacturing solid dosage forms with toxicity levels OEB 4 and 5–6. ENGENIUM GROUP


The Effect of Microcrystalline Cellulose–CaHPO4 Mixtures in Different Volume Ratios


on the Compaction and Structural–Mechanical Properties of Tablets. Valentyn Mohylyuk, Arturs Paulausks, Oskars Radzins, Liga Lauberte, Leading Research Group, Faculty of Pharmacy, Rīga Stradiņš University


33


16


PRODUCTION AND TECHNOLOGICAL EQUIPMENT 16


23 Marchesini Group celebrates 50 years of excellence 26


Solutions from Shinva Medical: Combining professionalism, European standards, and reliable service support


Computational Fluid Dynamics (CFD) methods in barrier technology. G. Guidi, IMA LIFE, S. Annoni, HPE Group


ANALYTICAL CONTROL 46


Solving peak separation issues in pharmaceutical laboratories: Comparing two methods of preparative chromatography. Khimlaborreactyv LLC


50


TRENDS IN THE PHARMA INDUSTRY 50 CPHI 2024 Annual Report:


23 4 BACK TO CONTENTS 54 The future of manufacturing:


Trends and Insights in Drug Delivery Devices Collaboration between humans and machines


www.promoboz.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60